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INTRODUCTION	

	
Complex regional pain syndrome (CRPS) is a chronic 
pain syndrome characterized by autonomic changes and pain 
in an extremity which is  out of proportion in intensity and 
duration  to  the  inciting  trauma.1,2  Pain  experienced  by 
individuals  with  CRPS  fluctuates  over  time  and  manifests 
episodic peaks.1 Many factors, such as temperature, activity 
level,  and  stress  may  contribute  to  the  appearance  of  pain 
flares.2  Stress  has  been  studied  as  a  factor  mediating  pain 
intensity  over  time,  yet  a  same-day  relationship  between 
perceived stress and pain intensity has not been supported.3 
However,  recent  studies  have  reported  notable  correlations 
between peak stress days and pain flares occurring ten days 
later in patients with fibromyalgia syndrome and CRPS.3,4 The 
hypothesized mechanism involves delayed activation of  the 
stress-related  hormone  thyroxine  via  the  hypothalamus-
pituitary-thyroid  (HPT)  axis  of  the  stress  response.5  After 
secretion,  thyroxine  is  bound  by  serum  proteins  then 
uncoupled over time into its active free state, producing peak 
systemic  effects  after  approximately  ten  days.6   Effects 
include  increased  peripheral  nerve  excitability,  central 
nervous  system  sensitization,  and  insomnia,  which  may 
mediate  both  nociceptive  input  intensity  and  cognitive 
interpretation of pain.5 While theoretically plausible, there is 
not  yet  evidence that  the stress-related release of  thyroxine 
temporally parallels changes in pain intensity for patients with 
chronic  pain  syndromes.5  Providing  some  explanation  for 
seemingly  unpredictable  pain  flares  may  help  patients  and 
therapists discriminate between stress-related flares and those 
caused by factors such as poor activity pacing or intensity of 
therapeutic activity.	

	

PURPOSE	

	
The  purpose  of  this  study  was  to  investigate  a 
hypothesized  psychophysiological  mechanism  for  recent 
findings that psychogenic stress episodes precipitate delayed 
flares in pain intensity occurring ten days after the stressful 
event  in  patients  with  complex  regional  pain  syndrome 
(CRPS).   Specifically,  this  study  assessed  temporal 
relationships  over  a  ten-week  period  between  daily  stress, 
perceived  pain  intensity,  pain-related  function,  and  serum 
levels of the stress-related hormone thyroxine in patients with 
CRPS.	

	

METHODS	

	
Three  patients  were  assessed  daily  for  ten  weeks  on 
stress,  pain  intensity,  pain-related  function,  and  serum 
thyroxine  (T4)  levels.  Each  day,  for  70  consecutive  days, 
patients completed a visual analog stress scale (VASS), visual 
analog  pain  scale  (VAPS),  an  individualized  visual  analog 
function  scale  (VAFS),  and  the  McGill  pain  questionnaire 
short  form  (SF-MPQ).  Throughout  the  ten-week  period 
patients  submitted  daily  blood  draws  for  T4  analysis.  Free 
serum T4 levels  were determined using microplate  enzyme 
immunoassays. To assess daily reliability of T4 assays, each 
daily  blood  sample  was  split  and  analyzed  twice  by  an 
independent laboratory, each time using separate procedures, 
separate  technicians,  and  reagent  kits  from  two  separate 
manufacturers.  Thyroxine  assays  yielded  a  free  T4  index 
(FTI) and two independent assessments of free T4. Samples 
were maintained at 2-8o C until analysis and all assays were 
conducted within seven days of collection.  Due to possible 
influences on pain and hormone activity, patients reported all 
daily medication usage and any menstrual activity.	

	

ANALYSIS	

	
Linear  regression  relationships  between  perceived 
stress,  pain,  and  FTI  were  analyzed  using  serial  lag 
correlations to determine occurrences of consistently delayed 
elevations  in  pain  or  free  T4.    Daily  stress  scores  were 
correlated with pain and T4 measures for same-day as well as 
each consecutive day’s pain and T4 scores up to a fourteen-
day lag.  Same-day product-moment correlation coefficients 
were calculated between pain and T4 scores.	

RESULTS	

	
Across  patients,  14  peak  stress  episodes  and  26 
significant pain flares were reported. Each stress episode was 
followed ten days by a significant pain flare and free T4 values 
exceeding  normal  adult  range  (2.4ng/dL).  Serial  lag 
correlations were strongest between stress and pain for pain 
experienced ten days after peak stress episodes (r=+0.381, p< 
0.05). FTI correlated strongest with stress ten days following a 
stressful episode (r =+0.454, p< 0.001).  Same-day pain and 
FTI correlated at r=+0.643, p< 0.001. Figures 1-4 illustrate the 
temporal responses of pain and thyroxine levels as a function 
of measured psychogenic stress for patient #1.	
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Figure 5. Summary of delayed pain modulation mechanism via T4 release and delayed influence on perceived pain intensity.	
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Figure 1.  Visual analog stress scores (VASS) with visual analog pain scores 
(VAPS) from ten days later across ten weeks.	
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Figure 2.  Serial lag correlations between daily visual analog stress scores and 
lagged pain up to a fourteen-day lag.	
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Figure 3.  Visual analog stress scores (VASS) with free thyroxine index (FTI) ten 
days later across ten weeks.	
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Figure 4.  Same-day visual analog pain scores (VAPS) with free thyroxine index 
(FTI) across ten weeks.	
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Discussion	

	
The findings  of  this  investigation  are  consistent  with 
prior research reporting a ten-day pain modulation effect due 
to psychogenic stress and lends support to the hypothesis that 
T4 release is at the root of the mechanism of pain modulation. 	

	
Via the HPT axis, thyoid hormones may modulate pain 
via  several  effects.   First,  by  elevating  peripheral  nerve 
excitability,  T4 increases peripheral nociceptive input to the 
dorsal horn without the necessity of an accompanying change 
at  a  distal  lesion  site.  Second,  via  reticular  core  activation 
from  increased  spinoreticular  input  and  direct  CNS 
sensitization, cerebration rates increase, resulting in elevated 
cortical  activity  and  anxiety.  Further,  high  cerebration  rates 
could  lead  to  episodic  insomnia  and  hence  elevated  pain 
perception secondary to sleep loss. Thyroxine could, therefore, 
increase the perceived intensity of pain by bringing a stronger 
pain signal into the CNS and ultimately deliver that message 
to a hyperaroused cortex that is more likely to interpret that 
message as severe, all without any change at the distal tissue 
level.  	
Thyroxine may additionally induce hyperalgesia 
in patients with neuropathic pain through an indirect pathway, 
by  increasing  levels  of  neurotropic  growth  factor  (NGF) 
resulting  in  an  upregulation  of  sodium ion  channels  in  the 
dorsal root ganglion (DRG).  Intravenous injections of NGF in 
human patients have resulted in hyperalgesia and deep tissue 
pain, which occurs at the site of injection. Thyroxine’s effect 
on  the  increase  in  NGF may,  therefore,  result  in  increased 
expression  of  sodium  gated  channels  leading  to  a 
hypersensitivity to pain. 7	

	

Conclusion	

	
Increased  pain  ten  days  following  stressful  events  is 
related to psychogenic HPT activity in CRPS patients.  Pain 
modulation  by  thyroxine  may  assist  understanding  pain 
fluctuation  etiology  and  suggest  new treatment  avenues  for 
managing neuropathic pain. 	

